Abingworth closes biotech fund
At $225m, Bioventures III LP closed $75m over its initial target, said the UK-based venture capitalist.
At $225m, Bioventures III LP closed $75m over its initial target, said the UK-based venture capitalist.
Copyright PEI Media
Not for publication, email or dissemination